Hester Biosciences Stock Company Profile

Description

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India. It operates through Poultry healthcare, Animal Healthcare, and Others segments. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals against Goat Pox, Peste des Petits Ruminants, and Brucellosis diseases, as well as infections, reproductive disorders, theileriosis, and parasitic diseases. In addition, the company provides feed supplements, such as growth tonic, toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment; herbal and nutrition products; and sanitizers. The company also exports its products. Hester Biosciences Limited has a collaboration agreement with Indian Institute of Technology Guwahati to develop vaccine against COVID-19. The company was incorporated in 1987 and is headquartered in Ahmedabad, India.